BU.150.715 Discovery to Market II Final Assessment Review 2026 (Qns & Ans

BU.150.715

Discovery to Market II


Final Assessment Review


(With Solutions)



2026




1

,1. Case: A researcher develops a novel biodegradable implant.
Question: At what point does the idea qualify as an invention?
- A. When it is marketed
- B. When it is novel, useful, and non-obvious
- C. When it is published
- D. When it is prototyped
Answer: B. Novel, useful, and non-obvious
Rationale: Patent law defines invention by novelty, utility, and non-
obviousness.

---

2. Case: A startup identifies a new diagnostic biomarker.
Question: Which IP protection is most appropriate?
- A. Trademark
- B. Copyright
- C. Patent
- D. Trade secret
Answer: C. Patent
Rationale: Biomarkers are patentable if novel and non-obvious.

---

3. Case: A health app is developed to monitor glucose.
Question: Which IP protection applies to the app’s name?
- A. Patent
- B. Trademark
- C. Copyright
- D. Trade secret
Answer: B. Trademark
Rationale: Trademarks protect brand names and logos.
2

, ---

4. Case: A novel drug shows promise in preclinical studies.
Question: What is the next step before human trials?
- A. NDA submission
- B. IND submission
- C. Phase III trial
- D. Market launch
Answer: B. IND submission
Rationale: Investigational New Drug application precedes human
testing.

---

5. Case: A researcher wants to protect a confidential formula.
Question: Which IP strategy is best?
- A. Patent
- B. Trade secret
- C. Trademark
- D. Copyright
Answer: B. Trade secret
Rationale: Trade secrets protect confidential know-how indefinitely.

---

6. Case: A new vaccine candidate enters Phase I trials.
Question: What is the primary goal?
- A. Efficacy
- B. Safety and dosage
- C. Marketability
- D. Long-term outcomes
Answer: B. Safety and dosage
3